KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Cash from Operations (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 36.56%
Dec 31, 2025 -65.78%
Sep 30, 2025 105.44%
Jun 30, 2025 63.91%
Mar 31, 2025 -70.84%
Dec 31, 2024 33.60%
Sep 30, 2024 45.22%
Jun 30, 2024 256.89%
Mar 31, 2024 28.07%
Dec 31, 2023 -80.51%
Sep 30, 2023 -32.83%
Jun 30, 2023 286.18%
Mar 31, 2023 -59.83%
Dec 31, 2022 -11.05%
Sep 30, 2022 54.30%
Jun 30, 2022 -10.81%
Mar 31, 2022 -22.93%
Dec 31, 2021 16.13%
Sep 30, 2021 25.22%
Jun 30, 2021 -8.22%
Mar 31, 2021 -2.28%
Dec 31, 2020 -36.07%
Sep 30, 2020 18.51%
Jun 30, 2020 33.18%
Mar 31, 2020 -15.12%
Dec 31, 2019 -25.56%
Sep 30, 2019 138.83%
Jun 30, 2019 -23.36%
Mar 31, 2019 -42.24%
Dec 31, 2018 -2.41%
Sep 30, 2018 55.71%
Jun 30, 2018 -22.92%
Mar 31, 2018 -9.46%
Dec 31, 2017 -12.80%
Sep 30, 2017 48.50%
Jun 30, 2017 -2.47%
Mar 31, 2017 -23.06%
Dec 31, 2016 16.45%
Sep 30, 2016 -0.56%
Jun 30, 2016 39.79%
Mar 31, 2016 -7.62%
Dec 31, 2015 -28.32%
Sep 30, 2015 -11.94%
Jun 30, 2015 121.59%
Mar 31, 2015 -47.85%
Dec 31, 2014 3.68%
Sep 30, 2014 23.08%
Jun 30, 2014 95.01%
Mar 31, 2014 -37.77%
Dec 31, 2013 1.55%
Sep 30, 2013 12.94%
Jun 30, 2013 52.53%
Mar 31, 2013 29.19%
Dec 31, 2012 -52.87%
Sep 30, 2012 -27.45%
Jun 30, 2012 144.34%
Mar 31, 2012 -38.64%
Dec 31, 2011 63.47%
Sep 30, 2011 -36.91%
Jun 30, 2011 49.13%
Mar 31, 2011 -48.71%
Dec 31, 2010 54.22%
Sep 30, 2010 -16.75%
Jun 30, 2010 71.30%
Mar 31, 2010 -49.92%
Dec 31, 2009 -7.70%
Sep 30, 2009 17.63%
Jun 30, 2009 95.46%